Gian Luca Negri

21PUBLICATIONS
127CO-AUTHORS
Cancer cell biologyMolecular targetsPredictive and prognostic markersSolid tumoursGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 15, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression.

Amal M El-Naggar, Yuqin Li, Busra Turgu

|Feb 21, 2025
Author Correction: Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.

A Contreras-Sanz, G L Negri, M J Reike

|Jan 31, 2025
Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.

A Contreras-Sanz, G L Negri, M J Reike

|Nov 22, 2024
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.

Cristiano Ferrario, John Mackey, Karen A Gelmon

|Jul 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinoma.

Rodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri

|Feb 07, 2024
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97.

Amir Pozner, Li Li, Shiv Prakash Verma

Pageof 4

Frequent Collaborators

11 joint publications

Gregg B Morin

6 joint publications

Sandra E Spencer Miko

5 joint publications

Amal M El-Naggar

4 joint publications

Christopher S Hughes